𝔖 Bobbio Scriptorium

✦ LIBER ✦

O66 Why has oral cancer survival not decreased multiple dimensions of oral cancer survival?

✍ Scribed by Chattopadhyay, A.

Book ID: 118655609
Publisher: Elsevier Science
Year: 2007
Weight: 48 KB
Volume: 2
Category: Article
ISSN: 1744-7895
DOI: 10.1016/s1744-7895(07)70102-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

WHY HAS THE SURVIVAL OF PATIENTS WITH BL

WHY HAS THE SURVIVAL OF PATIENTS WITH BLADDER CANCER NOT IMPROVED?

✍ Per-Uno Malmström 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

2099 ORAL Multiple lines of trastuzumab

2099 ORAL Multiple lines of trastuzumab provide a survival benefit for women with metastatic breast cancer: results from the Hermine cohort study

✍ E.C. Antoine; J.M. Extra; A. Vincent-Salomon; L. Bergougnoux L; F. Campana; M. N 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Induction chemotherapy prior to surgery

Induction chemotherapy prior to surgery did not improve survival, but may reduce mandibulectomy over surgery alone in locally advanced squamous cell cancer of the oral cavity: Abstracted from: Licitra L, Grandi C, Guzzo M et al. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 2003; 21: 327–33.

✍ Juan J Grau 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Uracil/tegafur plus oral leucovorin does

Uracil/tegafur plus oral leucovorin does not affect survival rates but may be better tolerated than standard fluorouracil and leucovorin for previously untreated metastatic colorectal cancer: Abstracted from: Douillard J, Hoff P, Skillings J et al. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology 2002; 20: 3605–16.

✍ Borut Stabuc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 82 KB